Tech in Pharma

Why it matters

Most of the conversation about AI in pharma is about drug discovery. Less visible is the shift happening in the commercial engine — pricing, contracting, rebates and market access — the dense, regulated machinery that decides whether an approved medicine reaches patients at a viable price.

This pillar covers where AI is genuinely changing that operation: moving processes from reactive to predictive, and the trust and governance questions that come with automating decisions that carry real regulatory and financial risk.

Tools